These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Kinetics of [123I]iodide uptake and discharge by perchlorate in studies of inhibition of iodide binding by antithyroid drugs. McCruden DC; Hilditch TE; Connell JM; Alexander WD Acta Endocrinol (Copenh); 1985 Dec; 110(4):499-504. PubMed ID: 2418616 [TBL] [Abstract][Full Text] [Related]
23. Cell-based imaging of sodium iodide symporter activity with the yellow fluorescent protein variant YFP-H148Q/I152L. Rhoden KJ; Cianchetta S; Stivani V; Portulano C; Galietta LJ; Romeo G Am J Physiol Cell Physiol; 2007 Feb; 292(2):C814-23. PubMed ID: 16987991 [TBL] [Abstract][Full Text] [Related]
24. Predicting neonatal perchlorate dose and inhibition of iodide uptake in the rat during lactation using physiologically-based pharmacokinetic modeling. Clewell RA; Merrill EA; Yu KO; Mahle DA; Sterner TR; Fisher JW; Gearhart JM Toxicol Sci; 2003 Aug; 74(2):416-36. PubMed ID: 12805655 [TBL] [Abstract][Full Text] [Related]
25. Genetic factors that might lead to different responses in individuals exposed to perchlorate. Scinicariello F; Murray HE; Smith L; Wilbur S; Fowler BA Environ Health Perspect; 2005 Nov; 113(11):1479-84. PubMed ID: 16263499 [TBL] [Abstract][Full Text] [Related]
26. Posttranscriptional regulation of sodium-iodide symporter mRNA expression in the rat thyroid gland by acute iodide administration. Serrano-Nascimento C; Calil-Silveira J; Nunes MT Am J Physiol Cell Physiol; 2010 Apr; 298(4):C893-9. PubMed ID: 20107044 [TBL] [Abstract][Full Text] [Related]
27. Expanded high-throughput screening and chemotype-enrichment analysis of the phase II: e1k ToxCast library for human sodium-iodide symporter (NIS) inhibition. Wang J; Richard AM; Murr AS; Buckalew AR; Lougee RR; Shobair M; Hallinger DR; Laws SC; Stoker TE Arch Toxicol; 2021 May; 95(5):1723-1737. PubMed ID: 33656581 [TBL] [Abstract][Full Text] [Related]
28. Kinetics of perrhenate uptake and comparative biodistribution of perrhenate, pertechnetate, and iodide by NaI symporter-expressing tissues in vivo. Zuckier LS; Dohan O; Li Y; Chang CJ; Carrasco N; Dadachova E J Nucl Med; 2004 Mar; 45(3):500-7. PubMed ID: 15001694 [TBL] [Abstract][Full Text] [Related]
29. Regulation and tissue distribution of the human sodium iodide symporter gene. Ajjan RA; Kamaruddin NA; Crisp M; Watson PF; Ludgate M; Weetman AP Clin Endocrinol (Oxf); 1998 Oct; 49(4):517-23. PubMed ID: 9876351 [TBL] [Abstract][Full Text] [Related]
30. Perchlorate, nitrate, and thiocyanate: Environmental relevant NIS-inhibitors pollutants and their impact on thyroid function and human health. Serrano-Nascimento C; Nunes MT Front Endocrinol (Lausanne); 2022; 13():995503. PubMed ID: 36339434 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of perturbations in serum thyroid hormones during human pregnancy due to dietary iodide and perchlorate exposure using a biologically based dose-response model. Lumen A; Mattie DR; Fisher JW Toxicol Sci; 2013 Jun; 133(2):320-41. PubMed ID: 23535361 [TBL] [Abstract][Full Text] [Related]
33. The sodium/iodide symporter: state of the art of its molecular characterization. Darrouzet E; Lindenthal S; Marcellin D; Pellequer JL; Pourcher T Biochim Biophys Acta; 2014 Jan; 1838(1 Pt B):244-53. PubMed ID: 23988430 [TBL] [Abstract][Full Text] [Related]
34. The use of physiologically based models to integrate diverse data sets and reduce uncertainty in the prediction of perchlorate and iodide kinetics across life stages and species. Clewell RA; Merrill EA; Robinson PJ Toxicol Ind Health; 2001 Jun; 17(5-10):210-22. PubMed ID: 12539865 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of iodide accumulation by perchlorate and thiocyanate in a model of the thyroid iodide transport system. Saito K; Yamamoto K; Takai T; Yoshida S Acta Endocrinol (Copenh); 1983 Dec; 104(4):456-61. PubMed ID: 6318492 [TBL] [Abstract][Full Text] [Related]
36. Iodine status in Turkish populations and exposure to iodide uptake inhibitors. Ozpinar A; Kelestimur F; Songur Y; Can O; Valentin L; Caldwell K; Arikan E; Unsal I; Serteser M; Inal T; Erdemgil Y; Coskun A; Bakirci N; Sezgin O; Blount B PLoS One; 2014; 9(2):e88206. PubMed ID: 24505430 [TBL] [Abstract][Full Text] [Related]
37. Phosphoinositide-3-kinase inhibition induces sodium/iodide symporter expression in rat thyroid cells and human papillary thyroid cancer cells. Kogai T; Sajid-Crockett S; Newmarch LS; Liu YY; Brent GA J Endocrinol; 2008 Nov; 199(2):243-52. PubMed ID: 18762555 [TBL] [Abstract][Full Text] [Related]
38. Use of the thyrocyte sodium iodide symporter as the basis for a perchlorate cell-based assay. MacAllister IE; Jakoby MG; Geryk B; Schneider RL; Cropek DM Analyst; 2009 Feb; 134(2):320-4. PubMed ID: 19173056 [TBL] [Abstract][Full Text] [Related]
39. High-Throughput Screening and Quantitative Chemical Ranking for Sodium-Iodide Symporter Inhibitors in ToxCast Phase I Chemical Library. Wang J; Hallinger DR; Murr AS; Buckalew AR; Simmons SO; Laws SC; Stoker TE Environ Sci Technol; 2018 May; 52(9):5417-5426. PubMed ID: 29611697 [TBL] [Abstract][Full Text] [Related]
40. Cloning of the human sodium lodide symporter. Smanik PA; Liu Q; Furminger TL; Ryu K; Xing S; Mazzaferri EL; Jhiang SM Biochem Biophys Res Commun; 1996 Sep; 226(2):339-45. PubMed ID: 8806637 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]